|
Patients (n)
|
13,155
| |
4943
| |
|
Age (median) [25th–75th]
|
63 [47–73]
| |
64 [52–73]
| |
|
Sex (%male)
|
57%
| |
57%
| |
|
APACHE II score (median) [25th–75th]
|
15 [11–19]
| |
15 [11–19]
| |
|
ICU length of stay (median) [25th–75th]
|
3 [2–6]
| |
3 [2–6]
| |
|
Hospital length of stay (median) [25th–75th]
|
15 [8–29]
| |
15 [9–28]
| |
|
Advanced cardiovascular support (% of patients)
|
23%
| |
26%
| |
|
Basic cardiovascular support (% of patients)
|
90%
| |
91%
| |
|
Advanced respiratory support (% of patients)
|
55%
| |
56%
| |
|
Basic respiratory support (% of patients)
|
63%
| |
64%
| |
|
Renal support (% of patients)
|
9%
| |
10%
| |
|
Neurological support (% of patients)
|
10%
| |
9%
| |
|
Liver support (% of patients)
|
0%
| |
0%
| |
|
Dermatological support (% of patients)
|
4%
| |
5%
| |
|
Gastrointestinal support (% of patients)
|
42%
| |
43%
| |
|
Respiratory tract infection
|
n = 1152
|
9%
|
n = 419
|
8%
|
|
Vascular procedure to major vessel
|
n = 881
|
7%
|
n = 399
|
8%
|
|
Large bowel tumour
|
n = 695
|
5%
|
n = 315
|
6%
|
|
Self-poisoning
|
n = 572
|
4%
|
n = 117
|
2%
|
|
Septicaemia and septic shock
|
n = 431
|
3%
|
n = 173
|
3%
|
|
Acute renal failure
|
n = 473
|
4%
|
n = 169
|
3%
|
|
COPD
|
n = 393
|
3%
|
n = 155
|
3%
|
|
Malignant neoplasm of oesophagus
|
n = 272
|
2%
|
n = 145
|
3%
|
|
Status epilepticus
|
n = 318
|
2%
|
n = 80
|
2%
|
|
Bowel perforation
|
n = 305
|
2%
|
n = 106
|
2%
|
|
Acute pancreatitis
|
n = 192
|
1%
|
n = 83
|
2%
|
|
Diabetic ketoacidosis
|
n = 217
|
2%
|
n = 57
|
1%
|
|
Asthma attack in new or known asthmatic patients
|
n = 201
|
2%
|
n = 83
|
2%
|
|
Ventricular tachycardia or fibrillation
|
n = 169
|
1%
|
n = 75
|
2%
|
|
Acute myocardial infarction
|
n = 175
|
1%
|
n = 66
|
1%
|
